237 related articles for article (PubMed ID: 27301979)
1. A targeted analysis reveals relevant shifts in the methylation and transcription of genes responsible for bile acid homeostasis and drug metabolism in non-alcoholic fatty liver disease.
Schiöth HB; Boström A; Murphy SK; Erhart W; Hampe J; Moylan C; Mwinyi J
BMC Genomics; 2016 Jun; 17():462. PubMed ID: 27301979
[TBL] [Abstract][Full Text] [Related]
2. NAFLD is associated with methylation shifts with relevance for the expression of genes involved in lipoprotein particle composition.
Mwinyi J; Boström AE; Pisanu C; Murphy SK; Erhart W; Schafmayer C; Hampe J; Moylan C; Schiöth HB
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Mar; 1862(3):314-323. PubMed ID: 27993651
[TBL] [Abstract][Full Text] [Related]
3. Chenodeoxycholic acid significantly impacts the expression of miRNAs and genes involved in lipid, bile acid and drug metabolism in human hepatocytes.
Krattinger R; Boström A; Lee SML; Thasler WE; Schiöth HB; Kullak-Ublick GA; Mwinyi J
Life Sci; 2016 Jul; 156():47-56. PubMed ID: 27174168
[TBL] [Abstract][Full Text] [Related]
4. The intrahepatic expression levels of bile acid transporters are inversely correlated with the histological progression of nonalcoholic fatty liver disease.
Okushin K; Tsutsumi T; Enooku K; Fujinaga H; Kado A; Shibahara J; Fukayama M; Moriya K; Yotsuyanagi H; Koike K
J Gastroenterol; 2016 Aug; 51(8):808-18. PubMed ID: 26601667
[TBL] [Abstract][Full Text] [Related]
5. Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease.
Mouzaki M; Wang AY; Bandsma R; Comelli EM; Arendt BM; Zhang L; Fung S; Fischer SE; McGilvray IG; Allard JP
PLoS One; 2016; 11(5):e0151829. PubMed ID: 27203081
[TBL] [Abstract][Full Text] [Related]
6. Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease.
Murphy SK; Yang H; Moylan CA; Pang H; Dellinger A; Abdelmalek MF; Garrett ME; Ashley-Koch A; Suzuki A; Tillmann HL; Hauser MA; Diehl AM
Gastroenterology; 2013 Nov; 145(5):1076-87. PubMed ID: 23916847
[TBL] [Abstract][Full Text] [Related]
7. Alterations in bile acid metabolizing gut microbiota and specific bile acid genes as a precision medicine to subclassify NAFLD.
Jiao N; Loomba R; Yang ZH; Wu D; Fang S; Bettencourt R; Lan P; Zhu R; Zhu L
Physiol Genomics; 2021 Aug; 53(8):336-348. PubMed ID: 34151600
[TBL] [Abstract][Full Text] [Related]
8. Targeted-bisulfite sequence analysis of the methylation of CpG islands in genes encoding PNPLA3, SAMM50, and PARVB of patients with non-alcoholic fatty liver disease.
Kitamoto T; Kitamoto A; Ogawa Y; Honda Y; Imajo K; Saito S; Yoneda M; Nakamura T; Nakajima A; Hotta K
J Hepatol; 2015 Aug; 63(2):494-502. PubMed ID: 25776890
[TBL] [Abstract][Full Text] [Related]
9. Identification of differentially methylated region (DMR) networks associated with progression of nonalcoholic fatty liver disease.
Hotta K; Kitamoto A; Kitamoto T; Ogawa Y; Honda Y; Kessoku T; Yoneda M; Imajo K; Tomeno W; Saito S; Nakajima A
Sci Rep; 2018 Sep; 8(1):13567. PubMed ID: 30206277
[TBL] [Abstract][Full Text] [Related]
10. Differentially methylated loci in NAFLD cirrhosis are associated with key signaling pathways.
Gerhard GS; Malenica I; Llaci L; Chu X; Petrick AT; Still CD; DiStefano JK
Clin Epigenetics; 2018 Jul; 10(1):93. PubMed ID: 30005700
[TBL] [Abstract][Full Text] [Related]
11. Serum Bile Acid Levels in Children With Nonalcoholic Fatty Liver Disease.
Jahnel J; Zöhrer E; Alisi A; Ferrari F; Ceccarelli S; De Vito R; Scharnagl H; Stojakovic T; Fauler G; Trauner M; Nobili V
J Pediatr Gastroenterol Nutr; 2015 Jul; 61(1):85-90. PubMed ID: 25729888
[TBL] [Abstract][Full Text] [Related]
12. Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis.
Bechmann LP; Kocabayoglu P; Sowa JP; Sydor S; Best J; Schlattjan M; Beilfuss A; Schmitt J; Hannivoort RA; Kilicarslan A; Rust C; Berr F; Tschopp O; Gerken G; Friedman SL; Geier A; Canbay A
Hepatology; 2013 Apr; 57(4):1394-406. PubMed ID: 23299969
[TBL] [Abstract][Full Text] [Related]
13. Branched chain amino acid transaminase 1 (BCAT1) is overexpressed and hypomethylated in patients with non-alcoholic fatty liver disease who experience adverse clinical events: A pilot study.
Wegermann K; Henao R; Diehl AM; Murphy SK; Abdelmalek MF; Moylan CA
PLoS One; 2018; 13(9):e0204308. PubMed ID: 30265706
[TBL] [Abstract][Full Text] [Related]
14. Unique features associated with hepatic oxidative DNA damage and DNA methylation in non-alcoholic fatty liver disease.
Nishida N; Yada N; Hagiwara S; Sakurai T; Kitano M; Kudo M
J Gastroenterol Hepatol; 2016 Sep; 31(9):1646-53. PubMed ID: 26875698
[TBL] [Abstract][Full Text] [Related]
15. Gene-metabolite network analysis in different nonalcoholic fatty liver disease phenotypes.
Liu XL; Ming YN; Zhang JY; Chen XY; Zeng MD; Mao YM
Exp Mol Med; 2017 Jan; 49(1):e283. PubMed ID: 28082742
[TBL] [Abstract][Full Text] [Related]
16. Non-alcoholic fatty liver disease is associated with dysregulated bile acid synthesis and diarrhea: A prospective observational study.
Appleby RN; Moghul I; Khan S; Yee M; Manousou P; Neal TD; Walters JRF
PLoS One; 2019; 14(1):e0211348. PubMed ID: 30682184
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide analysis of DNA methylation in human peripheral leukocytes identifies potential biomarkers of nonalcoholic fatty liver disease.
Zhang RN; Pan Q; Zheng RD; Mi YQ; Shen F; Zhou D; Chen GY; Zhu CY; Fan JG
Int J Mol Med; 2018 Jul; 42(1):443-452. PubMed ID: 29568887
[TBL] [Abstract][Full Text] [Related]
18. Gender-Specific Bile Acid Profiles in Non-Alcoholic Fatty Liver Disease.
Fitzinger J; Rodriguez-Blanco G; Herrmann M; Borenich A; Stauber R; Aigner E; Mangge H
Nutrients; 2024 Jan; 16(2):. PubMed ID: 38257143
[TBL] [Abstract][Full Text] [Related]
19. The Associations between Circulating Bile Acids and the Muscle Volume in Patients with Non-alcoholic Fatty Liver Disease (NAFLD).
Kobayashi Y; Hara N; Sugimoto R; Mifuji-Moroka R; Tanaka H; Eguchi A; Iwasa M; Hasegawa H; Iwata K; Takei Y; Taguchi O
Intern Med; 2017; 56(7):755-762. PubMed ID: 28381740
[TBL] [Abstract][Full Text] [Related]
20. Bile acid regulation: A novel therapeutic strategy in non-alcoholic fatty liver disease.
Yu Q; Jiang Z; Zhang L
Pharmacol Ther; 2018 Oct; 190():81-90. PubMed ID: 29684468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]